Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Harnessing bioprinted tissue to fight renal disease
July 2019
SHARING OPTIONS:

SAN DIEGO—A collaboration has been launched between Organovo Holdings Inc. and Prof. Melissa Little at the Murdoch Children's Research Institute, The Royal Children's Hospital (Melbourne, Australia) and Ton Rabelink at Universiteit Leiden. The partners are aiming to expand the use of 3D bioprinted stem cell-based therapeutic tissues to include approaches for treating end-stage renal disease. Funding for this undertaking comes from Stem Cells Australia and CSL Limited.
 
“Partnerships with world-class institutions can accelerate groundbreaking work in finding cures for critical unmet disease needs and the development of implantable therapeutic tissues," said Taylor J. Crouch, CEO of Organovo. “This collaboration is another important step in this direction. With the devoted support of Stem Cells Australia and CSL Limited, leading researchers are able to leverage Organovo’s powerful bioprinting technology platform to achieve significant breakthroughs.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.